CYCC

Q: What is the price of Cyclacel Pharmaceuticals (CYCC) today?

The current price of Cyclacel Pharmaceuticals (CYCC) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Cyclacel Pharmaceuticals (CYCC) pay dividends?

Cyclacel Pharmaceuticals (CYCC) did not pay dividends over the past year.

Cyclacel Pharmaceuticals Inc.

Price

$ -

return (12m)

0.00%

p/e

-2.47

p/bv

3.92

DIVIDEND YIELD

505.62%

CYCC price

CYCC

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CYCC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CYCC

review the fundamentals of Cyclacel Pharmaceuticals shares

P/E

-2.47

Sector: -4.11 Industry: -4.11

P/S (PSR)

Sector: -3.78 Industry: -3.78

P/BV

3.92

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

505.62%

Sector: - Industry: -

ROA

-131.14%

Sector: -61.23% Industry: -61.23%

ROE

-158.95%

Sector: -60.44% Industry: -60.44%

ROIC

-11,346.24%

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

0.00%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

0.00%

Sector: 37.92% Industry: 37.92%

OPERATING MARGIN

0.00%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

-1.49

Sector: -4.00 Industry: -4.00

EV/EBIT

-1.49

Sector: -4.22 Industry: -4.22

PRICE-TO-ASSETS

3.24

Sector: 1.44 Industry: 1.44

BVPS

1.82

Sector: 1.88 Industry: 1.88

EPS

-2.89

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.83

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.18

Sector: 0.38 Industry: 0.38

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-22.40%

Sector: - Industry: -

Fundamentals CYCC

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.93	7.08	33.81%	2.23%	$ 560.91 B	28.46%
PFE	20.17	1.68	8.35%	6.24%	$ 156.71 B	12.42%
ABBV	87.13	0.00	0.00%	3.19%	$ 368.21 B	6.91%
NVO	11.49	5.92	51.50%	4.60%	$ 179.95 B	33.05%
MRK	16.19	0.00	0.00%	2.79%	$ 295.53 B	28.08%
AZN	31.07	6.52	20.99%	1.56%	$ 317.64 B	17.41%
GILD	20.09	7.56	37.62%	2.32%	$ 170.95 B	28.90%
BMY	17.19	-3.56	-20.72%	4.18%	$ 121.26 B	14.64%
ZTS	20.05	16.09	80.25%	1.66%	$ 53.60 B	28.23%
REGN	17.16	2.47	14.41%	0.48%	$ 77.31 B	31.41%
HALO	25.80	167.51	649.21%	0.00%	$ 8.18 B	22.69%
AMGN	24.84	22.12	89.06%	2.72%	$ 191.51 B	20.98%
MCK	24.55	-1,076.41	-4,383.84%	0.37%	$ 106.56 B	1.09%
VRTX	28.35	6.00	21.18%	0.00%	$ 112.06 B	32.94%
CAH	30.39	-18.70	-61.56%	0.95%	$ 50.50 B	0.68%
HRMY	10.77	1.96	18.24%	0.00%	$ 1.71 B	18.27%
ADMA	17.83	5.49	30.78%	0.00%	$ 2.62 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CYCC Historical Dividends

current DY: 505.62%

5-year average DY: 101.12%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	04/29/2025	05/01/2025	0,15000000
Dividends	07/17/2016	08/01/2016	0,00750000

ABOUT Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

29 years

Founded: 1997

2006

Time since IPO - 20 years

12

Employees

Cyclacel Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $14.24 Millions, with shareholders equity totaling $3.63 Millions.

The company employs approximately 12 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Cyclacel Pharmaceuticals Inc. reported $- in revenue, generating net income of $-5.77 Millions.

Key financial metrics include a P/E ratio of -2.47, a price-to-book (P/B) ratio of 3.92, and a trailing twelve-month dividend yield of 505.62%.

The company trades under the ticker CYCC.

Market cap

$ 14.24 Millions

Net worth

$ 3.63 Millions

$ 3,630,000.00

Assets

$ 4.40 Millions

$ 4,400,000.00

Total Shares Outstanding

2.00 Millions

2,000,000

Average Daily Trading Volume

$ 2.25 Millions

$ 2,254,697.45

Sector

Health Care

Industry

Biotechnology

CYCC

CYCC revenue and profits

Financial Results CYCC

DRAG THE FRAME TO SEE MORE DATA

CYCC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 859.04 26,37% (12M)

P/E

24.55

0.37%

ROE

-4,383.84%

P/BV

-1,076.41

CAH - Cardinal Health

$ 211.18 62,81% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.70

JNJ - Johnson & Johnson

$ 230.69 51,98% (12M)

P/E

20.93

2.23%

ROE

33.81%

P/BV

7.08

PFE - Pfizer

$ 27.52 33,93% (12M)

P/E

20.17

6.24%

ROE

8.35%

P/BV

1.68

ABBV - AbbVie

$ 203.71 24,66% (12M)

P/E

87.13

3.19%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 117.10 55,88% (12M)

P/E

16.19

2.79%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 200.69 50,49% (12M)

P/E

31.07

1.56%

ROE

20.99%

P/BV

6.52

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 859.04 26,37% (12 M)

P/L

24.55

0.37%

ROE

-4,383.84%

P/VP

-1,076.41

CAH - Cardinal Health

$ 211.18 62,81% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.70

JNJ - Johnson & Johnson

$ 230.69 51,98% (12 M)

P/L

20.93

2.23%

ROE

33.81%

P/VP

7.08

PFE - Pfizer

$ 27.52 33,93% (12 M)

P/L

20.17

6.24%

ROE

8.35%

P/VP

1.68

ABBV - AbbVie

$ 203.71 24,66% (12 M)

P/L

87.13

3.19%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 117.10 55,88% (12 M)

P/L

16.19

2.79%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 200.69 50,49% (12 M)

P/L

31.07

1.56%

ROE

20.99%

P/VP

6.52

Frequently Asked Questions

What is the price of Cyclacel Pharmaceuticals (CYCC) today?

The current price of Cyclacel Pharmaceuticals (CYCC) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Cyclacel Pharmaceuticals (CYCC) pay dividends?

Cyclacel Pharmaceuticals (CYCC) did not pay dividends over the past year.

Is Cyclacel Pharmaceuticals (CYCC) a good investment?

Cyclacel Pharmaceuticals (CYCC) is currently trading at $ 0.00 with a P/E ratio of -2.47%. This represents a -19,268% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 505.62%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Cyclacel Pharmaceuticals (CYCC) stock?

You can buy Cyclacel Pharmaceuticals (CYCC) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CYCC and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Cyclacel Pharmaceuticals (CYCC) yield today?

Over the past month, Cyclacel Pharmaceuticals (CYCC) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.15 per share in dividends, resulting in a dividend yield of 505.62%.

If you were to purchase 100 shares of Cyclacel Pharmaceuticals (CYCC) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CYCC

Cyclacel Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CYCC

review the fundamentals of Cyclacel Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 505.62%

5-year average DY: 101.12%

type

Ex - Dividend Date

payment date

value

ABOUT Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Inc.

United States

29 years

2006

12

PROFIT X PRICE CYCC

Financial Results CYCC

CYCC cash flow

Asset, Revenue and Profit Growth - CYCC

CYCC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions